StockData
AstraZeneca PLC logo

AstraZeneca PLC

AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)

Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%

AstraZeneca Other CVRM medicines — Europe YoY actual by Quarter

Other CVRM medicines — Europe YoY actual (%) (%)

QuarterlyAnnual

AstraZeneca Other CVRM medicines — Europe YoY actual: -64.0% in Q2 2026, down 29.0 pts from a year earlier. That is the lowest of the 23 quarters on record here.

Latest, Q2 2026
-64.0%
Period ended Jun 30, 2026
Change on a year earlier
-29.0 pts
-35.0% in Q2 2025
History
23 quarters
Since Q4 2020
Sources
23
Documents cited below

Where the Q2 2026 figure comes from

“|| Other CVRM | 91 | | ( 34 ) | | ( 35 ) | | ( 7 ) | | n/m | | 70 | | 5 | | 2 | | 14 | | ( 64 ) | | ( 64 ) | | 14 | | ( 20 ) | | ( 14 )”

Source: Form 6-K FY2026Q2 Earnings Release ↗

Reported in Form 6-K / 20-F Product Sales Table.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedOther CVRM medicines — Europe YoY actual (%) (%)Year on yearSource
Q2 2026Jun 30, 2026-64.0%-29.0 ptsForm 6-K FY2026Q2 Earnings Release ↗
Q1 2026Mar 31, 2026-27.0%+12.0 ptsForm 6-K FY2026Q1 Earnings Release ↗
Q4 2025Dec 31, 2025-30.0%-27.0 ptsForm 6-K FY2025Q4 Earnings Release ↗
Q3 2025Sep 30, 2025-15.0%+13.0 ptsForm 6-K FY2025Q3 Earnings Release ↗
Q2 2025Jun 30, 2025-35.0%-26.0 ptsForm 6-K FY2025Q2 Earnings Release ↗
Q1 2025Mar 31, 2025-39.0%-28.0 ptsForm 6-K FY2025Q1 Earnings Release ↗
Q4 2024Dec 31, 2024-3.0%+28.0 ptsForm 6-K FY2024Q4 Earnings Release ↗
Q3 2024Sep 30, 2024-28.0%-27.0 ptsForm 6-K FY2024Q3 Earnings Release ↗
Q2 2024Jun 30, 2024-9.0%+14.0 ptsForm 6-K FY2024Q2 Earnings Release ↗
Q1 2024Mar 31, 2024-11.0%-6.0 ptsForm 6-K FY2024Q1 Earnings Release ↗
Q4 2023Dec 31, 2023-31.0%-20.0 ptsForm 6-K FY2023Q4 Earnings Release ↗
Q3 2023Sep 30, 2023-1.0%+26.0 ptsForm 6-K FY2023Q3 Earnings Release ↗
Q2 2023Jun 30, 2023-23.0%-42.0 ptsForm 6-K FY2023Q2 Earnings Release ↗
Q1 2023Mar 31, 2023-5.0%+15.0 ptsForm 6-K FY2023Q1 Earnings Release ↗
Q4 2022Dec 31, 2022-11.0%-9.0 ptsForm 6-K FY2022Q4 Earnings Release ↗
Q3 2022Sep 30, 2022-27.0%-87.0 ptsForm 6-K FY2022Q3 Earnings Release ↗

Cite this data

StockData. (2026). AstraZeneca Other CVRM medicines — Europe YoY actual (%), quarterly Q4 2020–Q2 2026 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/med-other-cvrm-eu-act-yoy

See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.